VBI VACCINES INC.: 10-Q filed 2015-07-31
What VBI VACCINES INC. reported in its quarterly report filed 2015-07-31 (fiscal Q2 2015): 24 published measures, 64 facts as tagged in accession 0001437749-15-014472.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-07-31
- Fiscal period
- fiscal Q2 2015
- Accession
- 0001437749-15-014472 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All VBI VACCINES INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 9,684,209 | USD | |
| At 2014-12-31 | 14,054,218 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 3,890,159 | USD | |
| At 2014-12-31 | 3,364,051 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 5,794,050 | USD | |
| At 2014-12-31 | 10,690,167 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 8,123,313 | USD | |
| At 2014-12-31 | 12,604,273 | USD | |
| At 2014-06-30 | 160,955 | USD | |
| At 2013-12-31 | 624,419 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -2,992,157 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -5,357,756 | USD | 181 |
| 2014-04-01 to 2014-06-30 | -2,196,584 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -4,047,418 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | 69,960 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 12,337 | USD | 181 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 250,960 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 250,960 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | -74,862,994 | USD | |
| At 2014-12-31 | -69,505,238 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 143,009 | USD | |
| At 2014-12-31 | 106,500 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | 478,600 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 24,800 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -2,783,975 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -4,977,182 | USD | 181 |
| 2014-04-01 to 2014-06-30 | -2,071,301 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -3,248,186 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 8,807,411 | USD | |
| At 2014-12-31 | 13,172,386 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 91,000 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 181,000 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 331,081 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 807,699 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 2,352,810 | USD | |
| At 2014-12-31 | 1,593,677 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 632,269 | USD | |
| At 2014-12-31 | 650,142 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 3,034,935 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 5,228,142 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 2,071,301 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 3,248,186 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 1,658,125 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 2,616,936 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 731,066 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 1,034,604 | USD | 181 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 79,577,191 | USD | |
| At 2014-12-31 | 79,098,591 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 50,552 | USD | |
| At 2014-12-31 | 67,513 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 895,541 | USD | |
| At 2014-12-31 | 568,535 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-06-30 | 415,520 | USD | |
| At 2014-12-31 | 400,827 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | -2,956,732 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -5,374,717 | USD | 181 |
| 2014-04-01 to 2014-06-30 | -2,435,713 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -4,090,824 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-04-01 to 2015-06-30 | 1,376,810 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 2,611,206 | USD | 181 |
| 2014-04-01 to 2014-06-30 | 1,340,235 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 2,213,582 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-06-30 | 64,018 | USD | 181 |
| 2014-01-01 to 2014-06-30 | 53,792 | USD | 181 |
Inspect the source
- Entity
- VBI VACCINES INC. / CIK 0000704159
- Captured
- SEC response SHA-256
ee368e2d96e5ef07072302038b381e02515061bdc1555e018ddbc4ec3acb200e
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000704159.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))